Mckesson Corporation & Affiliates U.S. Oncology and Rx Savings Solutions
Based in TX
AI Overview
With $22.7M in lobbying spend across 38 quarterly filings, Mckesson Corporation & Affiliates U.S. Oncology and Rx Savings Solutions is one of the biggest lobbying spenders in Washington. They deploy 17 individual lobbyists Their lobbying covers 7 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $1.6M |
| 2019 | $2.1M |
| 2020 | $1.5M |
| 2021 | $2.1M |
| 2022 | $3.8M |
| 2023 | $3.4M |
| 2024 | $3.4M |
| 2025 | $4.6M |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Mckesson Corporation & Affiliates U.S. Oncology and Rx Savings Solutions disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Health Issues, Medicare/Medicaid, Pharmacy, Veterans and 2 more
H.R./S.1: Tax Cuts and Jobs Act.
Implementation of Comprehensive Addiction and Recovery Act (CARA) PL 114-198 and education regarding opioid treatment and prevention; Implementation of 21st Century Cures (H.R. 34), advocacy related t
Physician and pharmacy reimbursement issues;
Legislation to amend Part B of title XVII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion; support for legislation to preserve patient access to oral oncolytics dispensed by commun
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.